Immune Therapeutics Inc Stock News

Immune Therapeutics (OTCMKTS: IMUN) is one of 909 public companies in the “Pharmaceutical preparations” industry, but how does it compare to its peers? We will compare Immune Therapeutics to related companies based on the strength of its analyst recommendations, profitability, institutional ownership, dividends, earnings, risk and valuation. Analyst Ratings This is a summary of recent […] The post Contrasting Immune Therapeutics (IMUN) and Its Peers appeared first on ETF Daily News .

Immune Therapeutics (OTCMKTS: IMUN) is one of 909 public companies in the Pharmaceutical preparations industry, but how does it weigh in compared to its peers? We will compare Immune Therapeutics to related businesses based on the strength of its profitability, institutional ownership, analyst recommendations, dividends, valuation, risk and earnings. Risk & Volatility Immune Therapeutics has []

Shorted stocks continue to be of interest to retail traders looking for the next big day trade and we're diving into some top candidates! The post The 10 Most Shorted Stocks Right Now for Friday, Dec.

Orlando, Florida , June 04, 2021 (GLOBE NEWSWIRE) -- Immune Therapeutics Inc. (OTC-PINK: IMUN) (the "Company") announced today that the Company has received and signed a non-binding term sheet to ente

Orlando, Florida , May 11, 2021 (GLOBE NEWSWIRE) -- Immune Therapeutics Inc. (OTC-PINK: IMUN) (the "Company") announced today that FINRA has processed a reverse split of 1-for 1,000 of the issued and